ICU Medical (NASDAQ:ICUI) Director Sells $11,635.00 in Stock

ICU Medical, Inc. (NASDAQ:ICUI – Get Free Report) Director Elisha Finney sold 65 shares of the stock in a transaction on Thursday, November 12th. The stock was sold at an average price of $179.00, for a total transaction of $11,635.00. Following the sale, the director directly owned 4,871 shares of the company’s stock, valued at $871,909. This represents a 1.32% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

ICU Medical Stock Performance

Shares of NASDAQ:ICUI opened at $179.27 on Monday. The firm has a market cap of $4.48 billion, a price-to-earnings ratio of 75.01, a PEG ratio of 2.26 and a beta of 0.88. ICU Medical, Inc. has a 12 month low of $113.37 and a 12 month high of $192.85. The company’s fifty day simple moving average is $163.72 and its 200 day simple moving average is $149.91. The company has a quick ratio of 1.19, a current ratio of 2.37 and a debt-to-equity ratio of 0.52.

ICU Medical (NASDAQ:ICUI – Get Free Report) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $2.44 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.30. The firm had revenue of $556.22 million during the quarter, compared to analyst estimates of $552.03 million. ICU Medical had a net margin of 2.76% and a return on equity of 8.40%. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the prior year, the business earned $2.03 EPS. As a group, research analysts forecast that ICU Medical, Inc. will post 7.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ICUI. BlackRock Inc. bought a new position in ICU Medical in the second quarter valued at approximately $550,250,000. Jupiter Topco LLC acquired a new position in shares of ICU Medical during the 2nd quarter worth approximately $407,786,000. Bank of America Corp DE acquired a new position in shares of ICU Medical during the 2nd quarter worth approximately $54,059,000. Reinhart Partners LLC. acquired a new position in shares of ICU Medical during the 2nd quarter worth approximately $46,148,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of ICU Medical during the 2nd quarter worth approximately $28,652,000. Institutional investors and hedge funds own 96.10% of the company’s stock.

Analysts Set New Price Targets

ICUI has been the topic of a number of research reports. Weiss Ratings upgraded ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Wall Street Zen raised ICU Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Needham & Company LLC increased their price objective on ICU Medical from $165.00 to $187.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Raymond James Financial reissued a “strong-buy” rating and issued a $200.00 target price on shares of ICU Medical in a research report on Friday, August 7th. Finally, BTIG Research boosted their target price on ICU Medical from $170.00 to $200.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $195.20.

Get Our Latest Analysis on ICU Medical

About ICU Medical

(Get Free Report)

ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.

Featured Articles

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.